These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17073516)

  • 1. Gliquidone contributes to improvement of type 2 diabetes mellitus management: a review of pharmacokinetic and clinical trial data.
    Malaisse WJ
    Drugs R D; 2006; 7(6):331-7. PubMed ID: 17073516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.
    Harrower AD
    Clin Pharmacokinet; 1996 Aug; 31(2):111-9. PubMed ID: 8853933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multicenter study with gliquidone in type 2 diabetes mellitus].
    Kreze A; Vozár J; Rázus P; Lacko A; Málek Z; Putz Z
    Vnitr Lek; 1991; 37(9-10):761-7. PubMed ID: 1771808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glibenclamide and gliquidone in the treatment of non-insulin-dependent diabetes mellitus.
    Nikkilä K; Groop L
    Acta Med Scand; 1982; 211(1-2):13-7. PubMed ID: 6803519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.
    Bonora E; Moghetti P; Querena M; Zenere M; Cacciatori V; Tosi F; Travia D; Zoppini G; Muggeo M
    J Endocrinol Invest; 1992 Jan; 15(1):1-11. PubMed ID: 1560186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined therapy with insulin/gliquidone (Glurenorm) in type 2 diabetes after treatment failure using oral antidiabetic agents].
    Podrouzková B; Krusová D
    Vnitr Lek; 1992 Oct; 38(10):963-7. PubMed ID: 1481374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliquidone ameliorates hepatic insulin resistance in streptozotocin-induced diabetic Sur1
    Zhang R; Zhou X; Sheng Q; Zhang Q; Xie T; Xu C; Zou Z; Dong J; Liao L
    Eur J Pharmacol; 2021 Sep; 906():174221. PubMed ID: 34081903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD; Balfour JA
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
    Rupprecht E; König E; Limmer J
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():31-2. PubMed ID: 8516203
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the effectiveness and tolerability of gliquidone in the treatment of diabetes mellitus type II].
    Iori I; Bosi E; Manicardi E; Del Din G; Dini FL; Portioli I
    Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):277-83. PubMed ID: 2640049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic control with gliquidone--a short acting sulphonylurea.
    Borthwick LJ; Wilson S
    Eur J Clin Pharmacol; 1984; 26(4):475-9. PubMed ID: 6428917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of gliquidone in Thai diabetics.
    Nitiyanant W; Sriussadaporn S; Deerochanawong C; Ngawngamrat S; Benjasuratwong Y; Patanaungkul S
    J Med Assoc Thai; 1997 Dec; 80(12):771-7. PubMed ID: 9470330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [40 years of using sulfonylurea derivatives for treatment of diabetes].
    Sieradzki J
    Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The newly developed sulfonylurea glimepiride: a new ingredient, an old recipe.
    Veneman TF; Tack CJ; van Haeften TW
    Neth J Med; 1998 May; 52(5):179-86. PubMed ID: 9652156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihyperglycaemic agents. Drug interactions of clinical importance.
    Scheen AJ; Lefèbvre PJ
    Drug Saf; 1995 Jan; 12(1):32-45. PubMed ID: 7741982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients.
    Rosenkranz B
    Horm Metab Res; 1996 Sep; 28(9):434-9. PubMed ID: 8911979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.